Literature DB >> 7794481

Depressive symptoms in Alzheimer's disease and multi-infarct dementia.

W E Reichman1, A C Coyne.   

Abstract

We examined the prevalence of major depression, depressed mood/anhedonia, and subjective and neurovegetative symptoms of depression that were unaccompanied by depressed mood/anhedonia in patients with clinically-diagnosed Alzheimer's disease (AD) and multi-infarct dementia (MID). The specificity of subjective and neurovegetative depressive symptoms for depressed mood in dementia was examined, as was the impact on depression of clinical variables such as family history, patient age, and dementia severity. Subjects were 105 outpatients who met DSM-III-R criteria for AD (n = 67) or MID (n = 38). Depressed mood/anhedonia was frequently noted in both the AD (40.3%) and MID (34.2%) groups. One or more depressive symptoms, not accompanied by depressed mood/anhedonia, were also common in AD and MID (49.3% and 36.8%, respectively). Major depression was relatively uncommon in AD (10.5%) but was noted more frequently in MID (29.0%). Among AD patients, neurovegetative symptoms of depression were not any more common in patients with depressed mood/anhedonia than in those without depressed mood/anhedonia. Subjective symptoms of depression were also not significantly associated with depressed mood/anhedonia. The study highlights the importance of viewing major depression, depressed mood-anhedonia, and other depressive symptoms (subjective and neurovegetative) as separate entities in AD and MID.

Entities:  

Mesh:

Year:  1995        PMID: 7794481     DOI: 10.1177/089198879500800203

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  9 in total

1.  Prevalence of Depression, Anxiety and PTSD in People with Dementia: a Systematic Review and Meta-Analysis.

Authors:  J K Kuring; J L Mathias; L Ward
Journal:  Neuropsychol Rev       Date:  2018-12-07       Impact factor: 7.444

2.  The role of medical comorbidity in outcome of major depression in primary care: the PROSPECT study.

Authors:  Hillary R Bogner; Mark S Cary; Martha L Bruce; Charles F Reynolds; Benoit Mulsant; Thomas Ten Have; George S Alexopoulos
Journal:  Am J Geriatr Psychiatry       Date:  2005-10       Impact factor: 4.105

Review 3.  Anhedonia in Neurodegenerative Diseases.

Authors:  Vicky Turner; Masud Husain
Journal:  Curr Top Behav Neurosci       Date:  2022

4.  Decreased serum brain-derived neurotrophic factor levels in elderly korean with dementia.

Authors:  Jung Goo Lee; Bae Sub Shin; Young Sun You; Ji Eun Kim; Sung Wook Yoon; Dong Wook Jeon; Jun Hyung Baek; Sung Woo Park; Young Hoon Kim
Journal:  Psychiatry Investig       Date:  2009-11-11       Impact factor: 2.505

5.  Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides.

Authors:  Manfred Windisch; Birgit Hutter-Paier; Edward Rockenstein; Makoto Hashimoto; Margaret Mallory; Eliezer Masliah
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

6.  Vascular depression: a new view of late-onset depression.

Authors:  G S Alexopoulos; M L Bruce; D Silbersweig; B Kalayam; E Stern
Journal:  Dialogues Clin Neurosci       Date:  1999-09       Impact factor: 5.986

7.  LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer's Disease.

Authors:  Bradlee L Heckmann; Brett J W Teubner; Bart Tummers; Emilio Boada-Romero; Lacie Harris; Mao Yang; Clifford S Guy; Stanislav S Zakharenko; Douglas R Green
Journal:  Cell       Date:  2019-06-27       Impact factor: 66.850

8.  Optimisation of cognitive performance in rodent operant (touchscreen) testing: Evaluation and effects of reinforcer strength.

Authors:  Benjamin U Phillips; Christopher J Heath; Zofia Ossowska; Timothy J Bussey; Lisa M Saksida
Journal:  Learn Behav       Date:  2017-09       Impact factor: 1.986

9.  IDEA intervention to prevent depressive symptoms and promote well-being in early-stage dementia: protocol for a randomised controlled feasibility study.

Authors:  Remco Tuijt; Gill Livingston; Rebecca L Gould; Rebecca Jones; Elisabet Sole Verdaguer; Vasiliki Orgeta
Journal:  BMJ Open       Date:  2018-02-08       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.